内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

ALUMIS INC.

ALMS · Nasdaq · CIK 0001847367 · Healthcare · Biotechnology

内部人信号

62.5 / 100

1 位买方 · 3 条买入交易行 · $8.3M 买入总额

为什么有这个信号？

买方广度较低
买入规模较强
角色较强
近期性中等
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+22.4 / 25
角色+20.0 / 20
近期性+5.0 / 10
确信度+8.1 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ✓ 角色得分高 · 买入者中职位最高的是：Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： AKKARAJU SRINIVAS · $8.3M
聚集买入 · 15天1 insider峰值活动： 2026-09-04–2026-09-08

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
AKKARAJU SRINIVASDirector
○●●▼
Pangali SanamChief Legal Officer
○▼▼
Drappa JornChief Medical Officer
○▼
Schroer John R.Chief Financial Officer
▼
Hardiman Roy C.Chief Business & Strategy Ofcr
▼
Goldstein David MChief Scientific Officer
▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.

信号历史

62.5 / 100

最新留档分数

↓ -0.1 pts相对上一个留档快照
  1. 63.0
  2. 62.9
  3. 62.8
  4. 62.6
  5. 62.5

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

39买入
9卖出
17其他 Form 4 交易行
33SEC 申报 · 365天
买入3 qualifying P line(s) · 180 days
卖出9 sale line(s) · 仅供背景
其他8 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-27.7%
3M
-74.5%
6M
-68.9%
12M
+61.6%

波动率与流动性

波动率
122.9%
Beta
—
平均每日成交额
USD 17.7M

估值

市值
—
P/E
—

基本面

利润率
—
ROE
-80.8%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
10,295,705
上期报告
6,299,106
日均成交量
2,869,547
回补天数
3.6

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-09-08AKKARAJU SRINIVAS买入 (P)Common Stock546,581USD 10.63USD 5,810,156SEC 申报 ↗
2026-09-04AKKARAJU SRINIVAS买入 (P)Common Stock220,070USD 11.17USD 2,458,182SEC 申报 ↗
2026-01-09AKKARAJU SRINIVAS买入 (P)Common Stock588,235USD 17.00USD 9,999,995SEC 申报 ↗
2026-01-08Tananbaum James B.买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2026-01-08Foresite Labs Affiliates 2021, LLC; Foresite Labs, LLC买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2026-01-08Foresite Capital Fund V, L.P.; Foresite Capital Fund VI LP; Foresite Capital Management V, LLC; Foresite Capital Management VI LLC; Foresite Capital Opportunity Fund V, L.P.; Foresite Capital Opportunity Management V, LLC; Foresite Labs Fund I, L.P.; Foresite Labs Management I, LLC; Labs Co-Invest V, LLC买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2025-12-05AKKARAJU SRINIVAS买入 (P)Common Stock186,377USD 9.84USD 1,833,760SEC 申报 ↗
2025-12-04AKKARAJU SRINIVAS买入 (P)Common Stock66,027USD 8.18USD 540,101SEC 申报 ↗
2025-12-03AKKARAJU SRINIVAS买入 (P)Common Stock100,000USD 7.75USD 775,000SEC 申报 ↗
2025-12-02AKKARAJU SRINIVAS买入 (P)Common Stock96,000USD 7.55USD 724,800SEC 申报 ↗
2025-12-01AKKARAJU SRINIVAS买入 (P)Common Stock86,350USD 7.46USD 644,171SEC 申报 ↗
2025-11-28AKKARAJU SRINIVAS买入 (P)Common Stock38,702USD 7.64USD 295,683SEC 申报 ↗
2025-11-26AKKARAJU SRINIVAS买入 (P)Common Stock48,537USD 7.64USD 370,823SEC 申报 ↗
2025-11-21Tananbaum James B.买入 (P)Common Stock72,212USD 7.38USD 532,925SEC 申报 ↗
2025-11-21Foresite Labs Affiliates 2021, LLC; Foresite Labs, LLC买入 (P)Common Stock72,212USD 7.38USD 532,925SEC 申报 ↗

Form 4 申报证据

65 transaction lines in the latest 365-day window; 151 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-08AKKARAJU SRINIVAS卖出 (S)Common Stock96,131USD 10.55USD 1,014,182SEC 申报 ↗
2026-09-08AKKARAJU SRINIVAS买入 (P)Common Stock546,581USD 10.63USD 5,810,156SEC 申报 ↗
2026-09-04AKKARAJU SRINIVAS买入 (P)Common Stock220,070USD 11.17USD 2,458,182SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-08AKKARAJU SRINIVAS卖出 (S)Common Stock96,131USD 10.55USD 1,014,182SEC 申报 ↗
2026-09-08AKKARAJU SRINIVAS买入 (P)Common Stock546,581USD 10.63USD 5,810,156SEC 申报 ↗
2026-09-04AKKARAJU SRINIVAS买入 (P)Common Stock220,070USD 11.17USD 2,458,182SEC 申报 ↗
2026-08-03Schroer John R.卖出 (S)Common Stock3,282USD 26.37USD 86,546SEC 申报 ↗
2026-08-03Pangali Sanam卖出 (S)Common Stock1,364USD 26.37USD 35,969SEC 申报 ↗
2026-08-03Hardiman Roy C.卖出 (S)Common Stock2,692USD 26.37USD 70,988SEC 申报 ↗
2026-08-03Goldstein David M卖出 (S)Common Stock2,596USD 26.37USD 68,457SEC 申报 ↗
2026-08-03Drappa Jorn卖出 (S)Common Stock2,447USD 26.37USD 64,527SEC 申报 ↗
2026-08-03Bradley Mark Christopher卖出 (S)Common Stock2,572USD 26.37USD 67,824SEC 申报 ↗
2026-07-06Pangali Sanam卖出 (S)Common Stock5,000USD 28.00USD 140,000SEC 申报 ↗
2026-07-06Pangali Sanam期权行权／转换 (M)Common Stock5,000USD 5.06USD 25,300SEC 申报 ↗
2026-06-30Yao Zhengbin奖励／授予 (A)Common Stock3,553USD 0.00USD 0SEC 申报 ↗
2026-06-30TETRAULT LYNN A.奖励／授予 (A)Common Stock3,553USD 0.00USD 0SEC 申报 ↗
2026-06-30Srivastava Sapna奖励／授予 (A)Common Stock3,553USD 0.00USD 0SEC 申报 ↗
2026-06-30Machado Patrick奖励／授予 (A)Common Stock3,553USD 0.00USD 0SEC 申报 ↗
2026-06-30AKKARAJU SRINIVAS奖励／授予 (A)Common Stock3,553USD 0.00USD 0SEC 申报 ↗
2026-05-22Drappa Jorn期权行权／转换 (M)Common Stock26,852USD 6.65USD 178,649SEC 申报 ↗
2026-04-01Tananbaum James B.J (J)Common Stock2,980,293USD 0.00USD 0SEC 申报 ↗
2026-04-01Foresite Labs Affiliates 2021, LLC; Foresite Labs, LLCJ (J)Common Stock2,980,293USD 0.00USD 0SEC 申报 ↗
2026-04-01Foresite Capital Fund V, L.P.; Foresite Capital Fund VI LP; Foresite Capital Management V, LLC; Foresite Capital Management VI LLC; Foresite Capital Opportunity Fund V, L.P.; Foresite Capital Opportunity Management V, LLC; Foresite Labs Fund I, L.P.; Foresite Labs Management I, LLC; Labs Co-Invest V, LLCJ (J)Common Stock2,980,293USD 0.00USD 0SEC 申报 ↗
2026-01-09AKKARAJU SRINIVAS买入 (P)Common Stock588,235USD 17.00USD 9,999,995SEC 申报 ↗
2026-01-08Tananbaum James B.买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2026-01-08Foresite Labs Affiliates 2021, LLC; Foresite Labs, LLC买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2026-01-08Foresite Capital Fund V, L.P.; Foresite Capital Fund VI LP; Foresite Capital Management V, LLC; Foresite Capital Management VI LLC; Foresite Capital Opportunity Fund V, L.P.; Foresite Capital Opportunity Management V, LLC; Foresite Labs Fund I, L.P.; Foresite Labs Management I, LLC; Labs Co-Invest V, LLC买入 (P)Common Stock411,764USD 17.00USD 6,999,988SEC 申报 ↗
2025-12-05AKKARAJU SRINIVAS买入 (P)Common Stock186,377USD 9.84USD 1,833,760SEC 申报 ↗
2025-12-04AKKARAJU SRINIVAS买入 (P)Common Stock66,027USD 8.18USD 540,101SEC 申报 ↗
2025-12-03AKKARAJU SRINIVAS买入 (P)Common Stock100,000USD 7.75USD 775,000SEC 申报 ↗
2025-12-02AKKARAJU SRINIVAS买入 (P)Common Stock96,000USD 7.55USD 724,800SEC 申报 ↗
2025-12-01AKKARAJU SRINIVAS买入 (P)Common Stock86,350USD 7.46USD 644,171SEC 申报 ↗
2025-11-28AKKARAJU SRINIVAS买入 (P)Common Stock38,702USD 7.64USD 295,683SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码ALMS
CIK0001847367
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史151 transaction lines from 2024-07-01 to 2026-09-08
58 P purchase lines · 9 S sale lines · 84 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.